Publications by Dr Angelika Kaufmann - ePrints

Browsing publications by Dr Angelika Kaufmann.

Newcastle Authors	Title	Year
Lucy Gentles Bojidar Goranov Elizabeth Matheson Dr Ashleigh Herriott Dr Angelika Kaufmann et al.	Exploring the frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types	2019
Professor Richard Edmondson Dr Angelika Kaufmann	Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative	2017
Dr Aiste McCormick Dr Peter Donoghue Michelle Dixon Dr Rachel O'Donnell James Murray et al.	Ovarian Cancers Harbour Defects in Non-Homologous End Joining Resulting in Resistance to Rucaparib	2017
Dr Rachel O'Donnell Dr Angelika Kaufmann Dr Laura Woodhouse Dr Aiste McCormick Professor Richard Edmondson et al.	Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity	2016
Dr Aiste McCormick Dr Rachel O'Donnell Dr Angelika Kaufmann	Phosphatase and Tensin Homolog Is a Potential Target for Ovarian Cancer Sensitization to Cytotoxic Agents	2016
Dr Aiste McCormick Dr Peter Donoghue Michelle Dixon Dr Rachel O'Donnell Dr Angelika Kaufmann et al.	Defects in non-homologous end joining pathway in ovarian cancers results in resistance to rucaparib	2015
Dr Rachel O'Donnell Dr Angelika Kaufmann Dr Aiste McCormick Professor Nicola Curtin Professor Richard Edmondson et al.	Intra- and inter-tumour heterogeneity in epithelial ovarian cancer: consequences for biomarker dependent stratification of therapies	2015
Dr Aiste McCormick Dr Rachel O'Donnell Dr Angelika Kaufmann Professor Richard Edmondson	Phosphatase and tensin homolog (PTEN) is a potential target for ovarian cancer sensitisation to cytotoxic agents	2015
Dr Aiste McCormick Michelle Dixon Dr Rachel O'Donnell Dr Angelika Kaufmann Professor Richard Edmondson et al.	PTEN function is important in determining ovarian cancer sensitivity to cytotoxic agents	2015
Dr Angelika Kaufmann Professor Richard Edmondson	The use of a p53 signature identifies a group of high risk endometrial cancer associated with an excellent prognosis	2015
Dr Miranda Patterson Dr Ian Forrest Becci Sharrock Maria Lane Dr Angelika Kaufmann et al.	Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples	2014
Laura Woodhouse Dr Aiste McCormick Dr Rachel O'Donnell Dr Angelika Kaufmann Professor Richard Edmondson et al.	Development of a Functional Assay to Determine the Nucleotide Excision Repair Status of Epithelial Overian Cancer	2014
Dr Rachel O'Donnell Dr Aiste McCormick Dr Asima Mukhopadhyay Michelle Dixon Dr Angelika Kaufmann et al.	The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis	2014
Dr Angelika Kaufmann Professor Richard Edmondson	Use of Molecular Markers Improves Prognostic Stratification in High Risk Endometrial Cancer: A Transportec Collaborative Study	2014
Dr Rachel O'Donnell Laura Woodhouse Dr Aiste McCormick Dr Asima Mukhopadhyay Michelle Dixon et al.	Functional Intra-Tumour Heterogeneity in Ovarian Cancer: What is a Representative Tumour Sample?	2013